Immunization Newsbriefs (c) Copyright Information Inc., Bethesda, MD. Brought to you by the National Network for Immunization Information (NNii). Visit NNii's new website at http://www.immunizationinfo.org.
------------------------------------------------------------
May 07, 2003
INTERNATIONAL IMMUNIZATION NEWS
"Osaka Univ. Researchers Develop Malaria Vaccine"
Daily Yomiuri (www.yomiuri.co.jp/index-e.htm) (05/07/03) P. 3
A team of researchers at Japan's Osaka University have developed a vaccine against malaria, made up of a protein produced by the plasmodium parasite that causes malaria. The vaccine is due to start clinical trials next spring, and it is intended to immunize against falciparum malaria, the most dangerous strain of the disease. The Osaka team worked on the serine repeat antigen protein, and the vaccine is based on protein that has been artificially produced. Team leader Prof. Toshihiro Horii suggested that the vaccine could be available for general use within five or six years.
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.